{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T21:15:43Z","timestamp":1783631743918,"version":"3.55.0"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Max-Planck-Society"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.jpsychires.2018.11.009","type":"journal-article","created":{"date-parts":[[2018,11,9]],"date-time":"2018-11-09T23:27:58Z","timestamp":1541806078000},"page":"48-51","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["abcb1ab p-glycoprotein is involved in the uptake of the novel antidepressant vortioxetine into the brain of mice"],"prefix":"10.1016","volume":"109","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0977-753X","authenticated-orcid":false,"given":"Derek","family":"Spieler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Namendorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Namendorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfred","family":"Uhr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpsychires.2018.11.009_bib1","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.2147\/NDT.S41387","article-title":"Pharmacology and clinical potential of vortioxetine in the treatment of major depressive disorder","volume":"10","author":"Alvarez","year":"2014","journal-title":"Neuropsychiatric Dis. Treat."},{"key":"10.1016\/j.jpsychires.2018.11.009_bib2","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1146\/annurev.pharmtox.39.1.361","article-title":"Biochemical, cellular, and pharmacological aspects of the multidrug transporter","volume":"39","author":"Ambudkar","year":"1999","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.jpsychires.2018.11.009_bib3","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/ajmg.b.32309","article-title":"ABCB1 gene variants and antidepressant treatment outcome: a meta-analysis","volume":"168B","author":"Breitenstein","year":"2015","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.jpsychires.2018.11.009_bib4","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.2217\/pgs.16.18","article-title":"ABCB1 genotyping in the treatment of depression","volume":"17","author":"Br\u00fcckl","year":"2016","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.jpsychires.2018.11.009_bib5","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.neuropharm.2015.12.009","article-title":"P-glycoprotein differentially affects escitalopram, levomilnacipran, vilazodone and vortioxetine transport at the mouse blood-brain barrier in vivo","volume":"103","author":"Bundgaard","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jpsychires.2018.11.009_bib6","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/BF00272381","article-title":"Localization of the human multiple drug resistance gene, MDR1, to 7q21.1","volume":"77","author":"Callen","year":"1987","journal-title":"Hum. Genet."},{"key":"10.1016\/j.jpsychires.2018.11.009_bib7","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1517\/17425255.2013.741589","article-title":"Species differences in drug transporters and implications for translating preclinical findings to humans","volume":"9","author":"Chu","year":"2013","journal-title":"Expet Opin. Drug Metabol. Toxicol."},{"key":"10.1016\/j.jpsychires.2018.11.009_bib8","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1073\/pnas.86.2.695","article-title":"Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites","volume":"86","author":"Cordon-Cardo","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jpsychires.2018.11.009_bib9","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1124\/dmd.104.001230","article-title":"The impact of P-glycoprotein on the disposition of drugs targeted for indications of the central nervous system: evaluation using the MDR1A\/1B knockout mouse model","volume":"33","author":"Doran","year":"2005","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jpsychires.2018.11.009_bib10","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1124\/dmd.107.017434","article-title":"In vitro P-glycoprotein assays to predict the in vivo interactions of P-glycoprotein with drugs in the central nervous system","volume":"36","author":"Feng","year":"2008","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jpsychires.2018.11.009_bib11","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1177\/0269881104042831","article-title":"P-glycoprotein reduces the ability of amitriptyline metabolites to cross the blood brain barrier in mice after a 10-day administration of amitriptyline","volume":"18","author":"Grauer","year":"2004","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2018.11.009_bib12","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1002\/jps.20686","article-title":"Kinetic analyses for species differences in P-glycoprotein-mediated drug transport","volume":"95","author":"Katoh","year":"2006","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jpsychires.2018.11.009_bib13","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1172\/JCI118699","article-title":"P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs","volume":"97","author":"Schinkel","year":"1996","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jpsychires.2018.11.009_bib14","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1056\/NEJMoa021986","article-title":"Association of multidrug resistance in epilepsy with a polymorphism in the drug-transporter gene ABCB1","volume":"348","author":"Siddiqui","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jpsychires.2018.11.009_bib15","doi-asserted-by":"crossref","first-page":"7735","DOI":"10.1073\/pnas.84.21.7735","article-title":"Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues","volume":"84","author":"Thiebaut","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jpsychires.2018.11.009_bib16","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0022-3956(03)00022-0","article-title":"abcb1ab P-glycoprotein is involved in the uptake of citalopram and trimipramine into the brain of mice","volume":"37","author":"Uhr","year":"2003","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jpsychires.2018.11.009_bib17","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jpsychires.2005.10.005","article-title":"Blood-brain barrier penetration and pharmacokinetics of amitriptyline and its metabolites in p-glycoprotein (abcb1ab) knock-out mice and controls","volume":"41","author":"Uhr","year":"2007","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jpsychires.2018.11.009_bib18","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S0893-133X(99)00095-0","article-title":"Penetration of amitriptyline, but not of fluoxetine, into brain is enhanced in mice with blood-brain barrier deficiency due to mdr1a P-glycoprotein gene disruption","volume":"22","author":"Uhr","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jpsychires.2018.11.009_bib19","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.neuron.2007.11.017","article-title":"Polymorphisms in the drug transporter gene ABCB1 predict antidepressant treatment response in depression","volume":"57","author":"Uhr","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.jpsychires.2018.11.009_bib20","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0022-3565(24)38809-3","article-title":"In vitro substrate identification studies for p-glycoprotein-mediated transport: species difference and predictability of in vivo results","volume":"296","author":"Yamazaki","year":"2001","journal-title":"J. Pharmacol. Exp. Therapeut."}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395617310798?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395617310798?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T11:11:10Z","timestamp":1758366670000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395617310798"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":20,"alternative-id":["S0022395617310798"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2018.11.009","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"abcb1ab p-glycoprotein is involved in the uptake of the novel antidepressant vortioxetine into the brain of mice","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychiatric Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychires.2018.11.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}